UBS Group
ASPN icon

UBS Group’s Aspen Aerogels ASPN Stock Holding History

UBS Group’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-224,700
Closed -$5.36M – 9489
2024
Q2 		$5.36M Buy
+224,700
New +$5.27M ﹤0.01% 2811

Other funds holding ASPN

KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $1.04B AUM 36.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

UBS Group's ASPN Position: Q2 2026 in Review

UBS Group reduced its Aspen Aerogels (ASPN) stake by 65% in Q2 2026, selling an estimated $601K and leaving 66,671 shares worth $423K. The position accounts for ﹤0.01% of the portfolio, ranked #6348.

UBS Group first reported a position in ASPN in Q4 2014 and has held it in 40 quarters since. The position peaked at $5.28M in Q1 2024. 179 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • UBS Group held 66,671 shares of Aspen Aerogels worth $423K as of Q2 2026.
  • UBS Group sold 122,558 Aspen Aerogels shares in Q2 2026, an estimated $601K.
  • Aspen Aerogels made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6348 holding.
  • UBS Group first reported a position in Aspen Aerogels in Q4 2014 and has held it in 40 quarters since.
  • UBS Group's Aspen Aerogels position peaked at $5.28M in Q1 2024.
  • 179 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.